Drug Discovery and the Market Today Part 1: An Overview of Externalisation in the Pharma Industry

Dr. David Elder is the Externalization Director for GlaxoSmithKline. Here, he talks exclusively on his perspective across the industry, including CROs, regulations, and strategising for efficiency, all ahead of his participation in this year's Improving Solubility conference.


To continue reading this story get free access